In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans

In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans

S Toräng, KN Bojsen-Møller, MS Svane… - American Journal of …, 2016 - Am Physiological Soc

... 21). PYY is synthesized and released from endocrine l-cells in the intestinal mucosa,
often together with proglugacon-derived peptides, namely glucagon-like peptide-1
(GLP-1), GLP-2, oxyntomodulin, and glicentin. PYY immunoreactive ...

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com